Impetigo epidemiology and demographics

Revision as of 17:40, 17 April 2017 by Usama Talib (talk | contribs)
Jump to navigation Jump to search

Impetigo Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Impetigo from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Impetigo epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Impetigo epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Impetigo epidemiology and demographics

CDC on Impetigo epidemiology and demographics

Impetigo epidemiology and demographics in the news

Blogs on Impetigo epidemiology and demographics

Directions to Hospitals Treating Impetigo

Risk calculators and risk factors for Impetigo epidemiology and demographics

Overview

Epidemiology and Demographics

=Incidence

  • In 2010, 140 million people suffered from impetigo.[1]

Age

  • Impetigo is more common among children.

References

  1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M; et al. (2012). "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2163–96. doi:10.1016/S0140-6736(12)61729-2. PMID 23245607.

Template:WH Template:WS